Plasma Symmetric Dimethylarginine and Mortality in Kidney Transplant Recipients
Kidney360 · 2026-08 · 7 (8) · 1873-1879
DOI: 10.34067/kid.0000001204 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kidney360, online erschienen am 04.05.2026. Verfasst von Daan Kremer und 10 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. Hauptthemen laut MEDLINE: Kidney Transplantation, Arginine. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Top Institute Food and Nutrition.
Abstract (Originalsprache)
Key Points In this large cohort of kidney transplant recipients, plasma symmetric dimethylarginine concentrations were independently associated with a higher mortality risk Symmetric dimethylarginine may not merely be an inert uremic solute and may be involved as a uremic toxin in ongoing pathological processes Background Long-term outcome after kidney transplantation remains limited because of high risks of cardiovascular, infectious, and malignant premature death. Uremic solutes, such as urea and symmetric dimethylarginine (SDMA), are suggested to contribute to higher oxidative stress, chronic low-grade inflammation, and excess mortality. Therefore, we evaluated the associations of urea and SDMA with all-cause and cause-specific mortality in kidney transplant recipients.
Methods
Baseline plasma SDMA was measured using liquid chromatography-mass spectrometry in kidney transplant recipients enrolled in the prospective TransplantLines Food and Nutrition Biobank and Cohort Study (Groningen, The Netherlands). We assessed prospective associations of SDMA with all-cause and cause-specific mortality using Cox regression.
Results
We included 628 adult kidney transplant recipients (56% male, age, 53±13 years; eGFR, 52±20 ml/min per 1.73 m 2 ) at 5.4 [interquartile range, 1.8–12.0] years after transplantation. Median plasma urea was 9.6 [7.3–13.4] mmol/L, and plasma SDMA was 20 [15–25] µ g/dl. In Cox regression analyses, both plasma urea (hazard ratio per doubling, 2.21; 95% confidence interval, 2.22 to 2.85) and plasma SDMA (hazard ratio per doubling, 2.69; 95% confidence interval, 1.95 to 3.70) were strongly associated with a higher risk of all-cause mortality. These associations remained for SDMA but not urea in a fully adjusted model, and the observed associations were generally similar for all causes of death.
Conclusions
Plasma urea and SDMA are both associated with a higher mortality risk in outpatient kidney transplant recipients. In a model including both urea and SDMA, only the association of SDMA with mortality remained. Clinical Trial registry name and registration number: NCT02811835.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Nephrology, Department of Internal Medicine, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
- Department of Public Health and Preventive Medicine, Faculty of Medicine Universitas Airlangga, Surabaya, Indonesia.
- IDEXX Laboratories, Inc, One IDEXX Drive, Westbrook, Maine.
- Division of Pharmacology and Therapy, Department of Anatomy, Histology, and Pharmacology, Faculty of Medicine Universitas Airlangga, Surabaya, Indonesia.
ORCID-Profile: Dion Groothof, Sovia Salamah, Adrian Post, Tim J Knobbe, Sarah Peterson, Marco van Londen, Stefan P Berger, Firas F Alkaff, Stephan J L Bakker
Förderung
- Top Institute Food and Nutrition
Zitieren
APA
Kremer, D., Groothof, D., Salamah, S., Post, A., Knobbe, T. J., Peterson, S., van Londen, M., Yerramilli, M., Berger, S. P., Alkaff, F. F., & Bakker, S. J. L. (2026). Plasma Symmetric Dimethylarginine and Mortality in Kidney Transplant Recipients. Kidney360, 7(8), 1873-1879. https://doi.org/10.34067/kid.0000001204
Vancouver
Kremer D, Groothof D, Salamah S, Post A, Knobbe TJ, Peterson S, et al. Plasma Symmetric Dimethylarginine and Mortality in Kidney Transplant Recipients. Kidney360. 2026;7(8):1873-1879. doi:10.34067/kid.0000001204
BibTeX
@article{Kremer2026,
author = {Kremer, Daan and Groothof, Dion and Salamah, Sovia and Post, Adrian and Knobbe, Tim J and Peterson, Sarah and van Londen, Marco and Yerramilli, Murthy and Berger, Stefan P and Alkaff, Firas F and Bakker, Stephan J L},
title = {Plasma Symmetric Dimethylarginine and Mortality in Kidney Transplant Recipients},
journal = {Kidney360},
year = {2026},
volume = {7},
number = {8},
pages = {1873--1879},
doi = {10.34067/kid.0000001204}
}
EUVIMED